Stock Earnings

Question 1

Elite Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Elite Pharmaceuticals Inc'in toplam varlıkları $96 olup, net loss $-4'dir.

Question 2

ELTP'ün temel finansal oranları nelerdir?

Accepted Answer

Elite Pharmaceuticals Inc'in cari oranı 2.28, net kâr marjı -4.76, hisse başına satış $0.07'dir.

Question 3

Elite Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Elite Pharmaceuticals Inc largest revenue segment is Abbreviated New Drug Applications, at a revenue of 84,043,929 in the most earnings release.For geography, United States is the primary market for Elite Pharmaceuticals Inc, at a revenue of 84,043,929.

Question 4

Elite Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Elite Pharmaceuticals Inc'in net loss $-4'dir.

Question 5

Elite Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Elite Pharmaceuticals Inc'in yükümlülüğü 42'dir.

Question 6

Elite Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Elite Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 1,068.36'dir.

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	105	84	56	34	32	25
Revenue Growth (YoY)	59%	50%	65%	6%	28%	47%
Cost of Revenue	46	43	30	17	17	13
Gross Profit	58	40	26	16	14	11
Selling, General & Admin	10	9	7	5	4	3
Research & Development	7	7	6	6	4	5
Operating Expenses	21	18	15	12	9	9
Other Non Operating Income (Expenses)	0	--	-5	--	--	--
Pretax Income	-1	0	0	3	6	4
Income Tax Expense	9	4	-19	0	-1	0
Net Income	-10	-4	20	3	8	5
Net Income Growth	-153%	-120%	567%	-63%	60%	-350%
Shares Outstanding (Diluted)	1,068.36	1,068.29	1,023.22	1,012.91	1,010.6	942.99
Shares Change (YoY)	-1%	4%	1%	0%	7%	13%
EPS (Diluted)	-0.01	0	0.01	0	0	0
EPS Growth	-153%	-120%	463%	-60%	63%	-300%
Free Cash Flow	18	4	-4	-2	6	2
Free Cash Flow Per Share	0.01	0	0	0	0	0
Gross Margin	55.23%	47.61%	46.42%	47.05%	43.75%	44%
Operating Margin	35.23%	25%	17.85%	8.82%	15.62%	8%
Profit Margin	-9.52%	-4.76%	35.71%	8.82%	25%	20%
Free Cash Flow Margin	17.14%	4.76%	-7.14%	-5.88%	18.75%	8%
EBITDA	38	22	11	4	6	3
EBITDA Margin	36.19%	26.19%	19.64%	11.76%	18.75%	12%
D&A For EBITDA	1	1	1	1	1	1
EBIT	37	21	10	3	5	2
EBIT Margin	35.23%	25%	17.85%	8.82%	15.62%	8%
Effective Tax Rate	-900%	0%	0%	0%	-16.66%	0%

Elite Pharmaceuticals Inc (ELTP) Price

ELTP Stock Price Chart

ELTP Income

Follow-Up Questions